Matthew L. Posard Insider Trading $TLIS Talis Biomedical Corp

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew L. Posard.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew L. Posard. Matthew L. Posard is Sr VP & General Manager in ILLUMINA INC ($ILMN) and Sr VP & GM, Consumer Genomics in ILLUMINA INC ($ILMN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Commercial Officer in Trovagene, Inc. ($XNOM.OB) and Director in Talis Biomedical Corp ($TLIS) and Director in DermTech, Inc. ($DMTK).

Matthew L. Posard in Talis Biomedical Corp

Trading Symbol: TLIS
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Matthew L. Posard: Director
Holdings: 62,500 shares
Latest Transaction: Feb 19 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Matthew L. Posard in Talis Biomedical Corp

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, XNOM.OB, DMTK, GYHT, ILMN, TLIS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 19 2021TLISTalis Biomedical C ...Posard Matthew L.DirectorBuyP16.0062,5001,000,00062,5000 to 62.5 K

Page:   1